Post Profile

Birth control for parasites: Researchers reveal new vaccine target for malaria

Scientists have identified a protein involved in the life cycle of the malarial parasite, paving the way for a new vaccine to reduce disease spread.
read more


Related Posts

Malaria study suggests drugs should target female parasites

Academics / General Science : Science Codex

Fresh insight into the parasite that causes malaria suggests a new way to develop drugs and vaccines to tackle the disease. Research into malaria parasites – which exist in male and female forms, and mate to spread the disease – sug...

Protein From Leishmania Parasites Is Sensitive To Anti-HIV Inhibitors And Could Be Target For Malaria And Other Parasitic Diseases

Health : Medical News Today

Scientists have discovered that drugs used to treat HIV may also one day become lifesaving drugs targeted at parasitic diseases such as leishmaniasis and malaria. According to new research published in The FASEB Journal, scientists ...

Anti-malaria drugs: Potential new target identified

Academics / Biology : EurekAlert: Biology

(Penn State) A newly described protein could be an effective target for combatting drug-resistant malaria parasites. The protein regulates a number of genes involved with a critical part of the parasite's complex life cycle -- its i...

Malaria vaccine target's invasion partner uncovered

Academics / General Science : ScienceDaily: Science Society

A team has discovered how a promising malarial vaccine target -- the protein RH5 -- helps parasites to invade human red blood cells. The study reveals that a previously mysterious protein on the surface of the parasite called P113 p...

Slamming the brakes on the malaria life cycle

Academics / General Science : Science Codex

Scientists have discovered a new target in their fight against the devastating global disease 'malaria' thanks to the discovery of a new protein involved in the parasite's life cycle. The research has uncovered a vital player in the...


Copyright © 2016 Regator, LLC